{"id":"W2394805951","doi":"10.1158/1538-7445.sabcs15-p5-14-01","title":"Abstract P5-14-01: A meta-analysis of clinical benefit rates for fulvestrant 500 mg versus alternative therapies for treatment of postmenopausal, estrogen receptor-positive advanced breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Fulvestrant; Medicine; Internal medicine; Oncology; Anastrozole; Odds ratio; Breast cancer; Clinical trial; Cancer; Confidence interval; Randomized controlled trial; Progression-free survival; Gynecology; Estrogen receptor; Tamoxifen; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01870856,0.003578158,0.0192016,0.003910049,0.0005533324,0.003841799,0.002207555,0.002839551,0.006072841],"category_scores_gemma":[0.02865425,0.001534377,0.06375671,0.003754902,0.0008527954,0.002126433,0.001609658,0.003598663,0.0006338711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002091996,"about_ca_system_score_gemma":0.001324843,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004334896,"about_ca_topic_score_gemma":0.005169803,"domain_scores_codex":[0.9845839,0.00987448,0.002555866,0.00166387,0.001010745,0.0003112233],"domain_scores_gemma":[0.9820786,0.01335798,0.002616106,0.0007227177,0.0008723066,0.0003523346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.007977422,0.00002204247,0.001713204,0.04158753,0.9450604,0.00006049953,0.00001963694,0.0006869426,0.0002175439,0.00009281007,0.0002941736,0.002267902],"study_design_scores_gemma":[0.002291211,0.0002644955,0.00166451,0.001601598,0.9928795,0.0000368845,0.00001255317,0.0003855068,0.00007712504,0.0002053749,0.0005676628,0.00001365391],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.04746092,0.9405915,0.004200095,0.0008476919,0.001031798,0.001158244,0.003056048,0.0002069647,0.001446696],"genre_scores_gemma":[0.86275,0.1236098,0.00456147,0.00208638,0.0006413837,0.002074589,0.002651658,0.0001461829,0.001478561],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0192016,"threshold_uncertainty_score":0.0989415,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2738566685408791,"score_gpt":0.534350758404024,"score_spread":0.2604940898631449,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}